Internal Medicine, Medical Oncology · Fort Smith, AR
NPI
1841295383
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1001 Towson Ave
Fort Smith, AR, 72901
Phone (479) 709-7435
Groups this clinician bills Medicare through
Medicare paid, 2024
$172K
4,386 services
Medicare patients, 2024
567
Average age 74
Drug cost, 2024
$4.5M
1,890 prescriptions
Company payments, 2025
$1,904
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zaki A Samman was code 36415 (venipuncture blood collection), 1,333 times for 469 patients. In total Zaki A Samman billed 4,386 services in 13 codes, and Medicare paid $172K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 1,333 | 469 | $8.65 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,138 | 422 | $11.92 | $14K |
| 99214 Office E&M - Established | Office | 916 | 321 | $84.99 | $78K |
| 99213 Office E&M - Established | Office | 614 | 366 | $52.91 | $32K |
| 99232 Hospital E&M - Subsequent | Facility | 156 | 47 | $54.84 | $8,555 |
| 99205 Office E&M - New | Office | 53 | 53 | $151.03 | $8,005 |
| 99204 Office E&M - New | Office | 53 | 53 | $106.93 | $5,667 |
| 99223 Hospital E&M - Initial | Facility | 53 | 49 | $119.97 | $6,359 |
| 99215 Office E&M - Established | Office | 41 | 33 | $129.54 | $5,311 |
| 38222 Other Organ Systems | Office | 21 | 21 | $105.83 | $2,223 |
By year: 2022 $134K for 2,465 services; 2023 $152K for 3,076 services; 2024 $172K for 4,386 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,333 | 469 | $8.65 | $12K |
Medicare prescription drug claims, 2024
In 2024, the drug Zaki A Samman prescribed most often to Medicare patients was Letrozole, with 150 prescriptions and refills. In total Zaki A Samman wrote 1,890 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 150 | 348 | 38 | $4,582 |
| Tamoxifen Citrate Generic | 101 | 223 | 22 | $1,996 |
| Hydroxyurea Generic | 92 | 195 | 20 | $1,972 |
| Warfarin Sodium Generic | 83 | 147 | Under 11 | $473 |
| Eliquis Apixaban | 83 | 87 | 14 | $48K |
| Imbruvica Ibrutinib | 60 | 60 | Under 11 | $756K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 55 | 55 | 40 | $755 |
| Levothyroxine Sodium Generic | 50 | 98 | 15 | $477 |
| Ondansetron Odt Ondansetron | 47 | 47 | 34 | $1,466 |
| Potassium Chloride Generic | 46 | 54 | 30 | $1,127 |
| Promethazine Hcl Generic | 45 | 45 | 27 | $335 |
| Xarelto Rivaroxaban | 45 | 59 | Under 11 | $35K |
| Xtandi Enzalutamide | 41 | 41 | Under 11 | $601K |
| Bicalutamide Generic | 40 | 64 | Under 11 | $1,086 |
| Gabapentin Generic | 32 | 66 | Under 11 | $677 |
Brand drugs: 495 claims; generic drugs: 1,395 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zaki A Samman $1,904 ($1,904 in general payments such as food, travel and fees) from 24 companies. The largest payer was Abbvie Inc. with $371.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 23 | $371 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $299 |
| Daiichi Sankyo Inc. 4568.T | 8 | $189 |
| GlaxoSmithKline, LLC. GSK | 12 | $168 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $117 |
| Merck Sharp & Dohme LLC MRK | 7 | $114 |
| Janssen Biotech, Inc. JNJ | 4 | $100 |
| Pfizer Inc. PFE | 5 | $91.22 |
| Eisai Inc. 4523.T | 4 | $83.35 |
| Aveo Pharmaceuticals, Inc. | 2 | $47.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.